Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O'Leary

Showing results (191-200 of 9,025) with videos related to

Pageof 903
Sort By:
Journal of Affective Disorders|November 25, 1996
The endogenous subtype and naturalistic course in depressionD O'Leary
Food and Drug Law Journal|March 20, 2014
Credible deterrence: FDA and the Park Doctrine in the 21st centuryPatrick O'Leary
Nature Medicine|May 19, 2022
Ethically incorporating patient perspectives into researchKaren O'Leary
Nature Medicine|May 13, 2022
A genetic cause of lupus revealedKaren O'Leary
Nature Medicine|June 18, 2021
Preventing breast cancer recurrenceKaren O'Leary
Nature Reviews. Cancer|December 2, 2020
Tracing the origins of KRAS oncogene addictionKaren O'Leary
Nature Medicine|December 15, 2021
Gene editing advances on all frontsKaren O'Leary
Nature Medicine|December 15, 2021
Advancing diversity, equity and inclusion in medicineKaren O'Leary
Nature Medicine|December 15, 2021
First CAR for multiple myelomaKaren O'Leary
Nature Medicine|December 15, 2021
FMT for patients with cancerKaren O'Leary
Pageof 903

Showing results (191-200 of 9,025) with videos related to

Sort By:
Pageof 903
Journal of Affective Disorders|November 25, 1996
The endogenous subtype and naturalistic course in depressionD O'Leary
Food and Drug Law Journal|March 20, 2014
Credible deterrence: FDA and the Park Doctrine in the 21st centuryPatrick O'Leary
Nature Medicine|May 19, 2022
Ethically incorporating patient perspectives into researchKaren O'Leary
Nature Medicine|May 13, 2022
A genetic cause of lupus revealedKaren O'Leary
Nature Medicine|June 18, 2021
Preventing breast cancer recurrenceKaren O'Leary
Nature Reviews. Cancer|December 2, 2020
Tracing the origins of KRAS oncogene addictionKaren O'Leary
Nature Medicine|December 15, 2021
Gene editing advances on all frontsKaren O'Leary
Nature Medicine|December 15, 2021
Advancing diversity, equity and inclusion in medicineKaren O'Leary
Nature Medicine|December 15, 2021
First CAR for multiple myelomaKaren O'Leary
Nature Medicine|December 15, 2021
FMT for patients with cancerKaren O'Leary
Pageof 903